Inj levoleucovorin nos 0.5mg
Products billed under this code include Levoleucovorin Calcium.
Payment limit per 0.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Levoleucovorin Calcium.
Payment limit per 0.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Levoleucovorin Calcium | Slate Run Pharmaceuticals | 70436-0209-80 | 350 | $18.55 |
| Levoleucovorin Calcium | Meitheal Pharmaceuticals Inc. | 71288-0104-10 | 100 | $5.30 |
| Levoleucovorin Calcium | Meitheal Pharmaceuticals Inc. | 71288-0105-18 | 350 | $18.55 |
| Levoleucovorin Calcium | Fosun Pharma USA Inc. | 72266-0120-01 | 350 | $18.55 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.053 | +$0.004 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted September 17, 2026 |
| 3Q26 | $0.049 | −$0.003 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted September 15, 2026 |
| 2Q26 | $0.052 | +$0.004 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted September 15, 2026 |
| 1Q26 | $0.048 | −$0.01 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted September 15, 2026 |
| 4Q25 | $0.058 | +$0.023 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted September 8, 2026 |
| 3Q25 | $0.035 | +$0.018 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted March 10, 2026 |
| 2Q25 | $0.017 | −$0.025 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted March 10, 2026 |
| 1Q25 | $0.042 | −$0.164 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted December 19, 2025 |
| 4Q24 | $0.206 | +$0.188 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 11, 2025 |
| 3Q24 | $0.018 | −$0.035 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 11, 2025 |
| 2Q24 | $0.053 | −$0.015 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted March 11, 2025 |
| 1Q24 | $0.068 | – | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted December 19, 2024 |
| 1Q23 | $0.266 | $0.00 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted December 6, 2023 |
| 4Q22 | $0.266 | +$0.173 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 22, 2023 |
| 3Q22 | $0.093 | −$0.011 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 9, 2023 |
| 2Q22 | $0.104 | −$0.009 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted December 14, 2022 |
| 1Q22 | $0.113 | +$0.025 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 8, 2022 |
| 4Q21 | $0.088 | +$0.008 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 2, 2022 |
| 3Q21 | $0.08 | −$0.044 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted June 2, 2022 |
| 2Q21 | $0.124 | +$0.009 | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted March 1, 2022 |
| 1Q21 | $0.115 | – | 0.5 MG | Inj levoleucovorin nos 0.5mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.